Can a 6-Week online program sharpen everyday thinking?

NCT ID NCT07743229

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This pilot study explores whether a personalized telerehabilitation program can help adults who notice cognitive slips in daily life. Participants include older adults and adults with Ehlers-Danlos Syndrome who report subjective cognitive complaints. Over six weeks, they receive 10 remote sessions combining cognitive strategies with occupational therapy to support memory, attention, and problem-solving in everyday tasks. The study measures changes in perceived cognitive function and whether the program is practical to complete.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
COG+OT Telerehabilitation, a personalized program combining cognitive rehabilitation and occupational therapy delivered remotely over 6 weeks
What this could lead to
If successful, this could offer a practical, home-based approach to help people with subjective cognitive complaints manage everyday thinking and memory challenges.
What could go wrong
This is a small pilot study, so results may not apply broadly. The intervention requires consistent participation, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of South Carolina

    Charleston, South Carolina, 29412, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.